Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-16

Clinical Trial Update: Disruption of Memory Reconsolidating as a Treatment for Panic Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating disruption of memory reconsolidation as a treatment for Panic Disorder. The sponsor is VU University of Amsterdam.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VU University of Amsterdam | Conditions: Panic Disorder | Phase 2 | Status: UNKNOWN